Revvity Cd16a (Fcgriiia, F158) Cellular Binding Kit, 10

Revvity The CD16a (FcgRIIIa, F158) cellular binding assay is a simple and robust test to monitor binding of the IgG Fc region to the human CD16a receptor in live cells and to select the most potent antibody for use in Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC). The assay can also be used to assess the degree of antibody afucosylation. Two separate CD16a assays are available to specifically target the V158 or F158 variants. These assays, based on our innovative Tag-lite technology, can easily be automated to create a high-throughput solution for predicting ADCC. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)